Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

305 results found

2024 ∙ Bardach, A. Ruvinsky, S. Palermo, M. C. Alconada, T. Sandoval, M. M. Brizuela, M. E. Wierzbicki, E. R. Cantos, J. Gagetti, P. Ciapponi, A.

Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis

  • Americas
  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Papagiannis, D. Kourek, C. Briasoulis, A. Fradelos, E. C. Papagianni, E. D. Papadimopoulos, I. Giamouzis, G. Skoularigis, J. Xanthopoulos, A.

Pneumococcal and Influenza Vaccination Coverage in Patients with Heart Failure: A Systematic Review

  • All age groups
  • Pneumococcal disease
  • Influenza
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Santangelo, O. E. Provenzano, S. Vella, C. Fermi, S. Facchini, L. Rizzo, M. Brighina, F. Cedrone, F. Firenze, A.

Safety and efficacy of vaccinations in patients with multiple sclerosis: a systematic review

  • All age groups
  • COVID-19
  • Influenza
  • Measles
  • Mumps
  • Rubella
  • Yellow fever
  • Varicella
  • Tetanus
  • Tick-borne encephalitis
  • Diphtheria
  • Pertussis
  • Meningococcal disease
  • Pneumococcal disease
  • Rabies
  • Haemophilus influenzae type B
  • Hepatitis B
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Du, P. Jin, S. Lu, S. Wang, L. Ma, X. Wang, J. Huang, R. Luo, Q. Yang, S. Feng, X.

Strategies to increase the coverage of influenza and pneumonia vaccination in older adults: a systematic review and network meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Price, O. Swanton, R. Grebely, J. Hajarizadeh, B. Webb, P. Peacock, A. Dore, G. J. Cowie, B. C. Vickerman, P. Degenhardt, L.

Vaccination coverage among people who inject drugs: A systematic review

  • All age groups
  • COVID-19
  • Hepatitis A
  • Hepatitis B
  • Human papillomavirus (HPV)
  • Influenza
  • Pneumococcal disease
  • Tetanus
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Pereira, A. Pinho, C. Oliveira, A. Santos, R. Felgueiras, M. Martins, J. P.

Vaccination Promotion Strategies in the Elderly: Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ NACI

Recommendations on the use of pneumococcal vaccines in adults, including PNEU-C-21

  • Recommendation
  • Americas
  • Canada
  • Adults
  • Pneumococcal disease
Download:
2024 ∙ NIAC

Updated recommendations for pneumococcal conjugate vaccination in childhood in Ireland

  • Recommendation
  • Europe
  • Ireland
  • Pneumococcal disease
Download:
2024 ∙ NACI

Economic Evidence Supplementary Appendix to the Recommendations for Public Health Programs on the Use of Pneumococcal Vaccines in Children, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines

  • Background paper
  • Americas
  • Canada
  • Pneumococcal disease
Download:
2024 ∙ NACI

Recommendations for public health programs on the use of pneumococcal vaccines in children, including the use of 15-valent and 20-valent conjugate vaccines

  • Recommendation
  • Americas
  • Canada
  • Pneumococcal disease
Download:
Loading...